应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06669 先瑞达医疗-B
未开盘 09-08 16:08:36
6.010
-0.120
-1.96%
最高
6.100
最低
5.960
成交量
65.40万
今开
6.100
昨收
6.130
日振幅
2.28%
总市值
18.81亿
流通市值
18.81亿
总股本
3.13亿
成交额
393.90万
换手率
0.21%
流通股本
3.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
先瑞达医疗-B8月股份变动月报:股本维持稳定
公告速递 · 09-01
先瑞达医疗-B8月股份变动月报:股本维持稳定
先瑞达医疗-B(06669.HK)公布中期业绩 净亏损8083.3万元 同比盈转亏
智通财经 · 08-31
先瑞达医疗-B(06669.HK)公布中期业绩 净亏损8083.3万元 同比盈转亏
先瑞达医疗-B 2026年上半年营收3.32亿元,经调整净利润0.91亿元
公告速递 · 08-31
先瑞达医疗-B 2026年上半年营收3.32亿元,经调整净利润0.91亿元
先瑞达医疗-B(06669)拟于8月31日召开董事会审议2026年中期业绩及分红方案
公告速递 · 08-19
先瑞达医疗-B(06669)拟于8月31日召开董事会审议2026年中期业绩及分红方案
盈警背后核心品种在美商业化受阻,先瑞达医疗-B(06669)股价腰斩何以反转?
智通财经 · 08-16
盈警背后核心品种在美商业化受阻,先瑞达医疗-B(06669)股价腰斩何以反转?
去年净利润归零!先瑞达医疗终止在美临床项目,背后是美国7月发布的一则文件
每日经济新闻 · 08-13
去年净利润归零!先瑞达医疗终止在美临床项目,背后是美国7月发布的一则文件
港股异动 | 先瑞达医疗-B(06669.HK)跌超10% 预计上半年盈转亏最多8090万元 终止临床项目产生减值拨备
智通财经 · 08-13
港股异动 | 先瑞达医疗-B(06669.HK)跌超10% 预计上半年盈转亏最多8090万元 终止临床项目产生减值拨备
前沿生物一高管持股比例降至5%以下;终止在美临床项目 先瑞达医疗2026年上半年预亏 | 医药早参
每日经济新闻 · 08-13
前沿生物一高管持股比例降至5%以下;终止在美临床项目 先瑞达医疗2026年上半年预亏 | 医药早参
先瑞达医疗-B(06669)发布盈利警告:2026年上半年料由盈转亏最高达80.9百万元
公告速递 · 08-12
先瑞达医疗-B(06669)发布盈利警告:2026年上半年料由盈转亏最高达80.9百万元
先瑞达医疗-B(06669)发盈警 预计中期净亏损不超过8090万元 同比盈转亏
智通财经 · 08-12
先瑞达医疗-B(06669)发盈警 预计中期净亏损不超过8090万元 同比盈转亏
先瑞达医疗-B发布7月股份变动月报,股本维持稳定
公告速递 · 08-05
先瑞达医疗-B发布7月股份变动月报,股本维持稳定
先瑞达医疗-B6月股份变动月报表:股本维持稳定
公告速递 · 07-02
先瑞达医疗-B6月股份变动月报表:股本维持稳定
先瑞达医疗-B5月无新增发行或股份变动
公告速递 · 06-03
先瑞达医疗-B5月无新增发行或股份变动
先瑞达医疗-B拟回购最多10%股份
公告速递 · 05-22
先瑞达医疗-B拟回购最多10%股份
格隆汇个股放量排行榜 | 5月9日
格隆汇 · 05-09
格隆汇个股放量排行榜 | 5月9日
先瑞达医疗-B4月无新增发行或股份变动
公告速递 · 05-06
先瑞达医疗-B4月无新增发行或股份变动
先瑞达医疗-B3月未有新增发行或股份变动
公告速递 · 04-09
先瑞达医疗-B3月未有新增发行或股份变动
先瑞达医疗-B(06669)公布2025年业绩 净利约1.19亿元 同比增长128%
智通财经 · 03-26
先瑞达医疗-B(06669)公布2025年业绩 净利约1.19亿元 同比增长128%
每日卖空追踪 | 先瑞达医疗-B 03月10日卖空量成交6000股,卖空比例为1.94%
市场透视 · 03-10
每日卖空追踪 | 先瑞达医疗-B 03月10日卖空量成交6000股,卖空比例为1.94%
先瑞达医疗-B盘中异动 股价大涨6.08%
市场透视 · 2025-03-11
先瑞达医疗-B盘中异动 股价大涨6.08%
加载更多
公司概况
公司名称:
先瑞达医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
先瑞达医疗科技控股有限公司是一家介入医疗器械中国公司。该公司专注于血管疾病介入治疗,涉及药物涂层球囊(DCB)、外周球囊扩张导管(PTA)等。该公司针对五大治疗领域建立产品组合,包括血管外科、心脏科、肾脏科、神经科及男科。该公司的业务遍及中国以及亚洲、欧洲等国家及地区。
发行价格:
--
{"stockData":{"symbol":"06669","market":"HK","secType":"STK","nameCN":"先瑞达医疗-B","latestPrice":6.01,"timestamp":1788854916005,"preClose":6.13,"halted":0,"volume":654000,"delay":0,"changeRate":-0.019575856443719432,"floatShares":313000000,"shares":313000000,"eps":0.389999,"marketStatus":"未开盘","change":-0.12,"latestTime":"09-08 16:08:36","open":6.1,"high":6.1,"low":5.96,"amount":3938965,"amplitude":0.022838,"askPrice":6,"askSize":3000,"bidPrice":5.995,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.185,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788917400000},"marketStatusCode":0,"adr":0,"listingDate":1629734400000,"exchange":"SEHK","adjPreClose":6.13,"openAndCloseTimeList":[[1788831000000,1788840000000],[1788843600000,1788854400000]],"volumeRatio":1.4364925336294088,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06669","defaultTab":"news","newsList":[{"id":"1151033773","title":"先瑞达医疗-B8月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1151033773","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151033773?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:52","pubTimestamp":1788252725,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司于2026年9月1日披露8月股份变动月报表,报告期为2026年8月。公告显示,公司法定/注册股本依旧保持在100,000美元,对应10,000,000,000股普通股,面值每股0.00001美元。截至2026年8月31日,公司已发行股份总数为313,389,171股,无库存股。公司同时确认,截至报告期末,已满足香港联交所关于公众持股量的相关要求。公司董事会声明,本月所有证券发行及股份处理事务均已获正式授权,并符合适用的上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663610070","title":"先瑞达医疗-B(06669.HK)公布中期业绩 净亏损8083.3万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2663610070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663610070?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:30","pubTimestamp":1788175816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1574","BK1100","06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174107097","title":"先瑞达医疗-B 2026年上半年营收3.32亿元,经调整净利润0.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174107097","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174107097?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:26","pubTimestamp":1788175619,"startTime":"0","endTime":"0","summary":"2026年上半年,先瑞达医疗-B实现营业收入3.32亿元,同比下降5.6%;经调整净利润0.91亿元,同比下降9.0%。同期毛利率为70.3%,较上年同期的74.2%减少3.9个百分点。销售及分销费用0.41亿元,同比下降26.8%,约占总收入的12.3%。行政开支0.32亿元,同比下降14.0%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"先瑞达医疗-B 2026年上半年营收3.32亿元,经调整净利润0.91亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162770458","title":"先瑞达医疗-B(06669)拟于8月31日召开董事会审议2026年中期业绩及分红方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1162770458","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162770458?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:42","pubTimestamp":1787132542,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B(06669)8月19日公告称,公司董事会将于2026年8月31日(星期一)召开会议,届时将审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及相关公告,并考虑派付中期股息(如有)。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659917435","title":"盈警背后核心品种在美商业化受阻,先瑞达医疗-B(06669)股价腰斩何以反转?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659917435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659917435?lang=zh_cn&edition=full","pubTime":"2026-08-16 15:04","pubTimestamp":1786863852,"startTime":"0","endTime":"0","summary":"8月12日盘后,先瑞达医疗-B披露了26H1财年盈警公告。从年内高点到股价“腰斩”由于最新盈警披露后,市场受利空影响较大,在8月13日公司股价大幅收跌超15%之后,先瑞达医疗股价于8月14日早盘再度下跌,盘中跌幅一度达到5.45%,股价跌至最低6.16港元,创下年内新低。3月26日,先瑞达医疗发布其2025年年报,其中公司当期净利润同比增长128%至1.19亿元,表现亮眼。然而财报净利润增长利好并未推动先瑞达股价的反弹增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1100","06669","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659581181","title":"去年净利润归零!先瑞达医疗终止在美临床项目,背后是美国7月发布的一则文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2659581181","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659581181?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:49","pubTimestamp":1786614544,"startTime":"0","endTime":"0","summary":"去年净利润归零!先瑞达医疗终止在美临床项目,背后是美国7月发布的一则文件","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840563753.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840563753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659823551","title":"港股异动 | 先瑞达医疗-B(06669.HK)跌超10% 预计上半年盈转亏最多8090万元 终止临床项目产生减值拨备","url":"https://stock-news.laohu8.com/highlight/detail?id=2659823551","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659823551?lang=zh_cn&edition=full","pubTime":"2026-08-13 09:44","pubTimestamp":1786585442,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1100","06669","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659186785","title":"前沿生物一高管持股比例降至5%以下;终止在美临床项目 先瑞达医疗2026年上半年预亏 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2659186785","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659186785?lang=zh_cn&edition=full","pubTime":"2026-08-13 07:03","pubTimestamp":1786575800,"startTime":"0","endTime":"0","summary":"丨2026年8月13日星期四丨NO.1阳光诺和控股股东、实控人协议转让5%股份过户完成8月12日,阳光诺和发布公告,称公司控股股东、实际控制人利虔与宁波宝隽资产管理有限公司代表的宝隽钱塘6号成长私募证券投资基金的股份协议转让过户登记手续已办理完毕。本次股份过户完成后,利虔持股比例为22.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133839573028.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133839573028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","06669","09939","159938","BK1161","BK1587","BK1515","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145852192","title":"先瑞达医疗-B(06669)发布盈利警告:2026年上半年料由盈转亏最高达80.9百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145852192","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145852192?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:26","pubTimestamp":1786530373,"startTime":"0","endTime":"0","summary":"2026年8月12日,先瑞达医疗科技控股有限公司公告称,根据对集团未经审核综合管理账目的初步评估,预计截至2026年6月30日止六个月将录得不超过人民币80.9百万元的净亏损,而去年同期则实现净利润约人民币88.6百万元。该决定引致约人民币150.8百万元的一次性非现金减值亏损及相关一次性开支拨备。公告强调,相关财务数据尚未经过核数师审计,实际业绩或与本次披露存在差异。公司预计将在2026年8月底前公布正式中期业绩报告。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976297","title":"先瑞达医疗-B(06669)发盈警 预计中期净亏损不超过8090万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976297","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658976297?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:24","pubTimestamp":1786530269,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先瑞达医疗-B 发布公告,本集团预期截至2026年6月30日止六个月将录得不超过人民币8090万元的净亏损,而截至2025年6月30日止六个月则录得净利润约人民币8860万元。预期业绩将由过往期间的净利润转为相关期间的净亏损,主要归因于终止 AcoArt Litos紫杉醇涂层经皮腔内血管成形术球囊导管(该产品)的美国临床试验项目,此举导致一笔一次性非现金减值亏损及一笔与终止临床项目相关的一次性开支拨备,合计约人民币1.51亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"先瑞达医疗-B(06669)发盈警 预计中期净亏损不超过8090万元 同比盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","06669","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157078112","title":"先瑞达医疗-B发布7月股份变动月报,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1157078112","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157078112?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:53","pubTimestamp":1785919985,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司于2026年8月5日公布截至2026年7月31日的月度证券变动情况。公告显示,公司本月未发生新增发行或回购,也无任何股份注销或库藏股变动。报告期末,公司已发行普通股股份数为313,389,171股,较上月底保持不变,库藏股份数量也维持为0股。公司确认其公眾持股量满足香港联交所相关规定。公司表示,所有财务及合规义务均按香港联交所《上市规则》及相关法律规定执行。截至本报告期末,公司总股本保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185384299","title":"先瑞达医疗-B6月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1185384299","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185384299?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:55","pubTimestamp":1782982505,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司于2026年7月2日公布截至2026年6月30日的股份变动月报表。报告期内,公司法定/注册股本维持10,000,000,000股普通股,面值为每股0.00001美元,总额为100,000美元,较上月无变化。在已发行股份方面,截至2026年6月30日,公司普通股数量为313,389,171股,库存股份数量为0股。报告期内,公司未进行新增发行、购回或注销操作,亦无股份期权、股权激励计划或可换股债券方面的新增授出、行使或失效情形。截至报告期末,公司股本整体保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180243814","title":"先瑞达医疗-B5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1180243814","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180243814?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:07","pubTimestamp":1780477665,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司于2026年6月3日发布截至2026年5月31日的股份变动月报表。公告显示,公司截至5月底的法定/注册股本未发生变化,仍为100,000美元。同月内并无新增发行、购回、注销或库藏股活动;且相关的股份期权或股权激励计划项下亦无数量变动。公司在报告中表示,所有股份及任何库藏股交易均已符合相关上市规则及适用法律法规,并由董事会正式审议和批准。公告由公司董事李静签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109019856","title":"先瑞达医疗-B拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1109019856","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109019856?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:36","pubTimestamp":1779438991,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司发布公告,董事会建议股东大会授予一般授权,以在香港联合交易所以不超过公司已发行股份总数10%的范围内回购股份。公告显示,截至2026年5月15日,公司已发行股份数为313,389,171股,若获股东批准且在股东大会结束后至下届股东大会召开前无进一步发行或回购,董事会可回购股份合计不超过31,338,917股。董事会表示,此次购回有助于提升公司价值和扩大股东的整体回报,符合公司及股东的最佳利益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先瑞达医疗-B拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634049003","title":"格隆汇个股放量排行榜 | 5月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2634049003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634049003?lang=zh_cn&edition=full","pubTime":"2026-05-09 17:30","pubTimestamp":1778319004,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,上一交易日福田股份(08196)、优博控股(08529)、大行科工(02543)、信利国际(00732)、绿茶集团(06831)、兴证国际(06058)、马可数字科技(01942)、富通科技(00465)、粤港湾控股(01396)、千百度(01028)、大酒店(00045)、希慎兴业(00014)、长和(00001)、普拉达(01913)、中国海外发展(00688)、港铁公司","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/09173057055514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00005","01396","02552","00752","02511","00118","00839","00550","00290","06978","01942","01028","02543","00085","02718","00412","00669","01828","00001","00819","01113","01083","06669","08529","00546","01401","00365","00117","00012","00215","00243","00688","00465","02418","00014","00279","00010","02632","00017","00069","00813","00066","00434","01140","02020","00045","01358","00732","06031","01876"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1126457653","title":"先瑞达医疗-B4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1126457653","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126457653?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:47","pubTimestamp":1778064427,"startTime":"0","endTime":"0","summary":"先瑞达医疗科技控股有限公司(股票代码:06669)于2026年5月6日披露2026年4月股份变动月报表。报告显示,公司法定注册股本维持在10,000,000,000股普通股(每股面值USD 0.00001),对应注册股本USD 100,000,与上月持平。\n报告期末已发行股份数为313,389,171股,较上月无变化;亦无任何股份回购或注销活动。公司于本月未有新增股份发行,也未进行任何库藏股行动。期权及股权激励计划方面,本月无相关新授出或行使记录。\n截至2026年4月30日,公司股本总数保持稳定。公告同时显示,公司确认已遵守香港联交所《上市规则》及相关法律规定。该报告由董事李静签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135893026","title":"先瑞达医疗-B3月未有新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1135893026","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135893026?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:51","pubTimestamp":1775724699,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B(股票代码:06669)于2026年4月9日发布截至2026年3月31日的股份变动月报表。公告显示,公司本月未发生新增股份发行、购回或注销等变动事项,股本结构整体保持不变。\n公告披露,截至报告期末,公司注册股本维持在10,000,000,000股,面值为每股USD 0.00001,总金额为USD 100,000。已发行股份总数为313,389,171股,与上月持平,库藏股数量亦为零。\n公告同时提及,公司未有期权计划或股份奖励计划项下的授予或行使变化,也未涉及任何购回及注销活动。公司确认一直遵守香港联交所《上市规则》及适用法律法规的相关要求。\n本次月报表由公司董事李静签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622285850","title":"先瑞达医疗-B(06669)公布2025年业绩 净利约1.19亿元 同比增长128%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285850","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622285850?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:09","pubTimestamp":1774516180,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先瑞达医疗-B 公布2025年业绩,收益约6.45亿元,同比增长20.7%;毛利约4.76亿元,同比增长18.3%;年内溢利约1.19亿元,同比增长128%;每股基本盈利0.4元。2025年是产品获批的收获期,公司成熟的多元化研发技术组合的协同效应取得成果。于报告期间,公司共获得国家药监局及北京药监局对11款产品的注册批准,其中多项产品代表了公司的里程碑式发布。同时,公司继续扩大全球布局。公司的外周射频消融系统于2025年10月获得美国FDA的510认证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06669","BK1100","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618569119","title":"每日卖空追踪 | 先瑞达医疗-B 03月10日卖空量成交6000股,卖空比例为1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618569119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618569119?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131437,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B北京时间03月10日,涨5.69%,卖空量成交6000股,较上一交易日减少60%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163527a6b4d75f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163527a6b4d75f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","06669","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518731403","title":"先瑞达医疗-B盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518731403?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:35","pubTimestamp":1741656903,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时35分,先瑞达医疗-B股票出现异动,股价快速拉升6.08%。截至发稿,该股报6.800港元/股,成交量3000股,换手率0.00%,振幅3.12%。先瑞达医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.12%。其相关个股中,先瑞达医疗-B、巨星医疗控股、中国卫生集团涨幅较大,振幅较大的相关个股有巨星医疗控股、心通医疗-B、心玮医疗-B,振幅分别为7.14%、7.14%、4.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093503abf4859e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093503abf4859e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","06669","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0491},{"period":"1month","weight":-0.219},{"period":"3month","weight":-0.2862},{"period":"6month","weight":-0.4832},{"period":"1year","weight":-0.6028},{"period":"ytd","weight":-0.5548}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":-0.0137},{"period":"3month","weight":0.0373},{"period":"6month","weight":-0.0155},{"period":"1year","weight":-0.0124},{"period":"ytd","weight":-0.0122}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先瑞达医疗科技控股有限公司是一家介入医疗器械中国公司。该公司专注于血管疾病介入治疗,涉及药物涂层球囊(DCB)、外周球囊扩张导管(PTA)等。该公司针对五大治疗领域建立产品组合,包括血管外科、心脏科、肾脏科、神经科及男科。该公司的业务遍及中国以及亚洲、欧洲等国家及地区。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.028525},{"month":2,"riseRate":0.4,"avgChangeRate":-0.042967},{"month":3,"riseRate":0.4,"avgChangeRate":-0.086882},{"month":4,"riseRate":0.6,"avgChangeRate":-0.065892},{"month":5,"riseRate":0.4,"avgChangeRate":0.024211},{"month":6,"riseRate":0.6,"avgChangeRate":0.075862},{"month":7,"riseRate":0.6,"avgChangeRate":0.085804},{"month":8,"riseRate":0.4,"avgChangeRate":-0.052476},{"month":9,"riseRate":0.5,"avgChangeRate":0.007948},{"month":10,"riseRate":0,"avgChangeRate":-0.071127},{"month":11,"riseRate":0.4,"avgChangeRate":0.019578},{"month":12,"riseRate":0.6,"avgChangeRate":0.087628}],"exchange":"SEHK","name":"先瑞达医疗-B","nameEN":"ACOTEC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先瑞达医疗-B(06669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先瑞达医疗-B(06669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先瑞达医疗-B,06669,先瑞达医疗-B股票,先瑞达医疗-B股票老虎,先瑞达医疗-B股票老虎国际,先瑞达医疗-B行情,先瑞达医疗-B股票行情,先瑞达医疗-B股价,先瑞达医疗-B股市,先瑞达医疗-B股票价格,先瑞达医疗-B股票交易,先瑞达医疗-B股票购买,先瑞达医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先瑞达医疗-B(06669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先瑞达医疗-B(06669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}